Loading
Curanosticum Wiesbaden-Frankfurt
Curanosticum is a nuclear medicine practice in Wiesbaden and Frankfurt led by Richard Baum, one of the pioneers of peptide receptor radionuclide therapy, offering FAPI PET and investigational radioligand therapies.
Overview
Curanosticum Wiesbaden-Frankfurt describes itself as modern nuclear medicine in the Rhine-Main region: precise diagnostics and individual therapy from an experienced team. Led by Richard Baum, it offers FAPI PET imaging and investigational radioligand therapies alongside established theranostics, and is patient-bookable through an oncology referral.
Location
Wiesbaden, DE
Type
hospital
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#501 · 6 points (0 Newsweek + 0 NCI + 6 from 3 linked objects) · ranking
People
1Connected
4Similar pages
- InstitutionExcel Diagnostics and Nuclear Oncology Center
Shares Radioligand therapy (beta emitters) and the tag fcct-directory.
- TrialAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- TrialA Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- TechnologyRadioligand dosimetry
Shares Lutetium-177 radioligand therapy, Radioligand therapy (beta emitters).
- PersonWolfgang A. Weber
- TrialAnti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- TrialStudy to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, o
- InstitutionPostgraduate Institute of Medical Education and Research, Chandigarh
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
curanosticum.de · 1
sijbrandijfoundation.org · 1
A source that has moved or gone is reported by the weekly link check. /audit/
ProvenanceLast edited 2026-09-17 · Jude Gomila · Mine institution networks (rows 110, 111) · diff · file
Sourced, not expert-reviewed